139 related articles for article (PubMed ID: 8693931)
21. Intracerebral hemorrhage as initial presentation of gestational choriocarcinoma: a case report and literature review.
Huang CY; Chen CA; Hsieh CY; Cheng WF
Int J Gynecol Cancer; 2007; 17(5):1166-71. PubMed ID: 17425677
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics of gestational trophoblastic disease at a single institute.
Alici S; Eralp Y; Saip P; Argon A; Basaran M; Topuz E; Aydiner A
Tohoku J Exp Med; 2002 Jun; 197(2):95-100. PubMed ID: 12233789
[TBL] [Abstract][Full Text] [Related]
23. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
Lurain JR; Brewer JI
Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
[TBL] [Abstract][Full Text] [Related]
24. Gestational trophoblastic disease metastatic to the central nervous system.
Evans AC; Soper JT; Clarke-Pearson DL; Berchuck A; Rodriguez GC; Hammond CB
Gynecol Oncol; 1995 Nov; 59(2):226-30. PubMed ID: 7590478
[TBL] [Abstract][Full Text] [Related]
25. Metastatic placental site trophoblastic tumor. Report of a case with complete response to chemotherapy.
Mangili G; Garavaglia E; De Marzi P; Zanetto F; Taccagni G
J Reprod Med; 2001 Mar; 46(3):259-62. PubMed ID: 11304870
[TBL] [Abstract][Full Text] [Related]
26. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
27. Twenty-five years' clinical experience with placental site trophoblastic tumors.
Papadopoulos AJ; Foskett M; Seckl MJ; McNeish I; Paradinas FJ; Rees H; Newlands ES
J Reprod Med; 2002 Jun; 47(6):460-4. PubMed ID: 12092014
[TBL] [Abstract][Full Text] [Related]
28. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
[TBL] [Abstract][Full Text] [Related]
29. Prolonged remission of recurrent, metastatic placental site trophoblastic tumor after chemotherapy.
Randall TC; Coukos G; Wheeler JE; Rubin SC
Gynecol Oncol; 2000 Jan; 76(1):115-7. PubMed ID: 10620452
[TBL] [Abstract][Full Text] [Related]
30. Placental site trophoblastic tumor presenting as subaponeurotic metastasis.
Aoki Y; Kase H; Kashima K; Yahata T; Tanaka K
Int J Gynecol Cancer; 2005; 15(2):385-8. PubMed ID: 15823131
[TBL] [Abstract][Full Text] [Related]
31. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Holden L
Br J Obstet Gynaecol; 1991 Jun; 98(6):550-7. PubMed ID: 1651757
[TBL] [Abstract][Full Text] [Related]
32. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Lurain JR; Nejad B
Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
[TBL] [Abstract][Full Text] [Related]
33. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
34. Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital.
Bianconi MI; Otero S; Moscheni O; Alvarez L; Storino C; Jankilevich G
J Reprod Med; 2012; 57(7-8):341-9. PubMed ID: 22838252
[TBL] [Abstract][Full Text] [Related]
35. Placental site trophoblastic tumour: five challenges of patient clinical management.
Peixinho C; Almeida A; Bartosch C; Cruz Pires M
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33509882
[TBL] [Abstract][Full Text] [Related]
36. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.
Fülöp V; Szigetvári I; Szepesi J; Végh G; Singh M; Berkowitz RS
J Reprod Med; 2012; 57(7-8):310-8. PubMed ID: 22838247
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
Song SQ; Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
[TBL] [Abstract][Full Text] [Related]
38. Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?
Gillespie AM; Siddiqui N; Coleman RE; Hancock BW
Br J Cancer; 1999 Mar; 79(7-8):1270-2. PubMed ID: 10098770
[TBL] [Abstract][Full Text] [Related]
39. Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment.
Hoekstra AV; Keh P; Lurain JR
J Reprod Med; 2004 Jun; 49(6):447-52. PubMed ID: 15283052
[TBL] [Abstract][Full Text] [Related]
40. Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy.
Gadducci A; Carinelli S; Guerrieri ME; Aletti GD
Gynecol Oncol; 2019 Jun; 153(3):684-693. PubMed ID: 31047719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
